{
  "id": "mhgap#management_a20f3c33",
  "content": "34. Slee A, Nazareth I, Bondaronek P, Liu Y, Cheng anxiety disorders: a systematic review and meta-\nZ, Freemantle N. Pharmacological treatments analysis. Arch Psychiatr Nurs. 2018;32(2):278–84\nfor generalised anxiety disorder: a systematic (https://doi.org/10.1016/j.apnu.2017.11.015).\nreview and network meta-analysis. Lancet.\n42. Ramos-Sanchez CP, Schuch FB, Seedat S, Louw\n2019;393(10173):768–77 (https://doi.org/10.1016/\nQA, Stubbs B, Rosenbaum S et al. The anxiolytic\nS0140-6736(18)31793-8).\neffects of exercise for people with anxiety and\n35. Parker EL, Banfield M, Fassnacht DB, Hatfield T, related disorders: an update of the available meta-\nKyrios M. Contemporary treatment of anxiety analytic evidence. Psychiatry Res. 2021;302:114046\nin primary care: a systematic review and meta- (https://doi.org/10.1016/j.psychres.2021.114046).\nanalysis of outcomes in countries with universal\n43. Vancampfort D, Sánchez CPR, Hallgren M,\nhealthcare. BMC Fam Pract. 2021;22(1):92 (https://\nSchuch F, Firth J, Rosenbaum S et al. Dropout\ndoi.org/10.1186/s12875-021-01445-5).\nfrom exercise randomized controlled trials\n36. Haller H, Breilmann P, Schröter M, Dobos G, among people with anxiety and stress-related\nCramer H. A systematic review and meta- disorders: a meta-analysis and meta-regression.\nanalysis of acceptance-and mindfulness-based J Affect Disord. 2021;282:996–1004 (https://doi.\ninterventions for DSM-5 anxiety disorders. Sci Rep. org/10.1016/j.jad.2021.01.003).\n2021;11(1):20385 (https://doi.org/10.1038/s41598-\n44. Machado S, Telles G, Magalhaes F, Teixeira D,\n021-99882-w).",
  "metadata": {
    "source": "WHO mhGAP-IG 2023",
    "url": "https://www.who.int/",
    "condition": "General",
    "risk_band": "low",
    "topics": [
      "stress",
      "work",
      "coping_skill",
      "management"
    ],
    "is_clinical": true,
    "is_advice": false
  },
  "index_text": "General — Management 34. Slee A, Nazareth I, Bondaronek P, Liu Y, Cheng anxiety disorders: a systematic review and meta-\nZ, Freemantle N. Pharmacological treatments analysis. Arch Psychiatr Nurs. 2018;32(2):278–84\nfor generalised anxiety disorder: a systematic (https://doi.org/10.1016/j.apnu.2017.11.015).\nreview and network meta-analysis. Lancet.\n42. Ramos-Sanchez CP, Schuch FB, Seedat S, Louw\n2019;393(10173):768–77 (https://doi.org/10.1016/\nQA, Stubbs B, Rosenbaum S et al. The anxiolytic\nS0140-6736(18)31793-8).\neffects of exercise for people with anxiety and\n35. Parker EL, Banfield M, Fassnacht DB, Hatfield T, related disorders: an update of the available meta-\nKyrios M. Contemporary treatment of anxiety analytic evidence. Psychiatry Res. 2021;302:114046\nin primary care: a systematic review and meta- (https://doi.org/10.1016/j.psychres.2021.114046).\nanalysis of outcomes in countries with universal\n43. Vancampfort D, Sánchez CPR, Hallgren M,\nhealthcare. BMC Fam Pract. 2021;22(1):92 (https://\nSchuch F, Firth J, Rosenbaum S et al. Dropout\ndoi.org/10.1186/s12875-021-01445-5).\nfrom exercise randomized controlled trials\n36. Haller H, Breilmann P, Schröter M, Dobos G, among people with anxiety and stress-related\nCramer H. A systematic review and meta- disorders: a meta-analysis and meta-regression.\nanalysis of acceptance-and mindfulness-based J Affect Disord. 2021;282:996–1004 (https://doi.\ninterventions for DSM-5 anxiety disorders. Sci Rep. org/10.1016/j.jad.2021.01.003).\n2021;11(1):20385 (https://doi.org/10.1038/s41598-\n44. Machado S, Telles G, Magalhaes F, Teixeira D,\n021-99882-w). 34. slee a, nazareth i, bondaronek p, liu y, cheng lo âu disorders: a systematic review and meta-\nz, freemantle n."
}